Entrada Therapeutics (TRDA) Amortizatization of Intangibles (2022 - 2026)

Entrada Therapeutics' Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $548000.0 for Q1 2026.

• In Q1 2026, Amortizatization of Intangibles fell 59.04% year-over-year to $548000.0; the TTM figure through Mar 2026 stood at $2.9 million (down 69.08% YoY), while the FY2025 annual figure was $3.7 million, down 63.36% from the prior year.
• Amortizatization of Intangibles was $548000.0 for Q1 2026 at Entrada Therapeutics, down from $633000.0 in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $3.2 million in Q3 2024 to a low of -$145000.0 in Q2 2022.
• Historically, Amortizatization of Intangibles has averaged $1.2 million across 5 years, with a median of $961000.0 in 2025.
• The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles surged 5687.5% in 2023, then plunged 77.0% in 2025.
• A 5-year view of Amortizatization of Intangibles shows it stood at $104000.0 in 2022, then soared by 1822.12% to $2.0 million in 2023, then advanced by 25.41% to $2.5 million in 2024, then slumped by 74.75% to $633000.0 in 2025, then declined by 13.43% to $548000.0 in 2026.
• The last three Amortizatization of Intangibles figures came in at $548000.0 (Q1 2026), $633000.0 (Q4 2025), and $739000.0 (Q3 2025), per Business Quant data.